Global spinal biologics market to reach $2.55B by 2024 — 3 insights

The global spinal biologics market is projected to grow at a 3.6 percent compound annual growth rate to reach $2.55 billion by 2024, according to a Market Study Report.

Advertisement

Three things to know about the global spinal biologics market:

1. North America is the largest supplier of spinal biologics, with a production market share of nearly 63 percent.

2. Europe is the second-largest spinal biologics supplier, with a production market share of nearly 28 percent.

2. Market competition is not intense, according to the report. Medtronic, DePuy Synthes, Stryker, NuVasive and Zimmer Biomet are the key market players; in 2015, Medtronic had a 40 percent market share.

More articles on spine surgery: 
The spine surgery devices, techniques that won’t stand the test of time
How spine surgeons view consolidation in healthcare
4 spine, neurosurgeons on the move in February

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.